Fingerprint
Dive into the research topics of 'Combined-modality therapy for unresectable, stage III non-small-cell lung cancer - Caveat emptor or caveat venditor?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Combined-modality therapy for unresectable, stage III non-small-cell lung cancer - Caveat emptor or caveat venditor?
Research output: Contribution to journal › Editorial › peer-review
5
Scopus
citations